Novo Nordisk is encouraged by White House proposals that could support patients using weight-loss drugs, but cautioned that ...

Novo Nordisk's shares rose due to President Joe Biden's proposal to expand Medicare and Medicaid coverage for anti-obesity ...

Novo Nordisk A/S is cutting back on recruiting in Denmark after reaching the limits of its home country’s labor market in the ...

Shares of Novo Nordisk gained 1.3% following U.S. President Biden's proposal to expand Medicare and Medicaid coverage for ...

Novo Nordisk and Ypsomed’s 2023 deal is rumoured to include an autoinjector supply for potential Wegovy successor CagriSema.

Novo Nordisk Foundation CEO Mads Krogsgaard Thomsen said only 9 million people are using GLP-1s compared with 1 billion ...

The world’s largest philanthropic fund that ultimately controls Novo Nordisk A/S will ramp up its investments outside of ...

Good day, and thank you for standing by. Welcome to the third-quarter 2024 Novo Nordisk A/S earnings conference call. [Operator instructions] Please be advised that today's conference is being ...

Welcome to the Third Quarter 2024 Novo Nordisk A/S Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question ...

“Novo Nordisk expects to file for regulatory approvals in the U.S. and EU in the first half of 2025. The detailed results from ESSENCE will be presented at a scientific conference in 202 ...

Novo Nordisk has announced a €1.025 billion ... Cardior will speak at the Oligonucleotide Therapeutics and Delivery conference on non-coding RNA-based therapeutics in heart disease.

Novo Nordisk said it expects to file for regulatory ... The company plans to present the detailed results from SOUL at a scientific conference in 2025. Founded in the late 1990s by Andrew ...